By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
10 luxury brand logos have mastered it. They've become more than marks on products—they're cultural touchstones, over decades and continents. Logos are stories we tell ourselves. The best ones?
Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...
We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...
Stella McCartney, Marzotto Wool Manufacturing Srl, Fashion for Good, and 13 new companies and organizations have joined the BioCircular Materials Alliance (the "Alliance"), led by biomaterials ...
Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...
Carvykti (西达基奥仑赛)是传奇和强生合作开发的一款靶向 BCMA CAR-T 疗法,已经在中国、美国、欧盟、日本等多个国家和地区上市。 黄颖博士介绍,相较于标准疗法,Carvykti 是首个且唯一一个在多发性骨髓瘤中显著延长 OS 的细胞疗法。该产品可以在医院或者 ...
Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma 13.01.2025 / 08:17 CET/CEST The issuer is solely responsible for the ...
ESO-T01 is an immune shielded lentiviral vector that specifically reprograms T lymphocytes in vivo into highly effective BCMA CAR-T cells. The multi-center, single arm, open-label, dose escalation ...
Purpose: Based on the efficacy data from the previous study of B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell injection, we further examined the delayed toxicity for 8 weeks ...
You are authorized to access and use the university’s trademarks for non-commercial purposes. You will comply with all posted policies, including our Trademark and Licensing Policy. We may suspend or ...